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Follicular B cell survival requires signaling from
BAFFR, a receptor for BAFF and the B cell antigen
receptor (BCR). This ‘‘tonic’’ BCR survival signal is
distinct from that induced by antigen binding and
may be ligand-independent. We show that inducible
inactivation of the Syk tyrosine kinase, a key signal
transducer from the BCR following antigen binding,
resulted in the death of most follicular B cells
because Syk-deficient cells were unable to survive
in response to BAFF. Genetic rescue studies demon-
strated that Syk transduces BAFFR survival signals
via ERK and PI3 kinase. Surprisingly, BAFFR sig-
naling directly induced phosphorylation of both Syk
and the BCR-associated Iga signaling subunit, and
this Syk phosphorylation required the BCR. We
conclude that the BCR and Iga may be required for
B cell survival because they function as adaptor
proteins in a BAFFR signaling pathway leading to
activation of Syk, demonstrating previously unrecog-
nized crosstalk between the two receptors.
INTRODUCTION
B lymphocytes play a critical role in the adaptive immune
response, in part by producing high affinity antibodies to patho-
gens. There are at least three main lineages of mature B cells.
Recirculating follicular B cells reside in the follicles of secondary
lymphoid organs and traffic between them through the blood
and lymphatic circulations; marginal zone (MZ) B cells are
located in the periphery of the splenic white pulp and are largely
nonrecirculating; B1 cells are found predominantly in the perito-
neal and pleural cavities. The total number of mature naive
(unactivated) B cells remains largely constant despite contin-
uous production of new B cells in the bone marrow as well as
recruitment of naive B cells into antigen-activated compart-
ments, such as germinal center cells, plasma cells, and memory
B cells. This homeostasis of mature B lymphocytes is known to
depend on at least two receptors: BAFFR (TNFRSF13C) and the
B cell antigen receptor (BCR).
Mice deficient in BAFFR or its ligand BAFF (TNFSF13B) have
substantially reduced numbers of follicular and MZ B cells, butunaltered numbers of B1 cells (Gross et al., 2001; Mackay
et al., 2010; Miller and Hayes, 1991; Sasaki et al., 2004; Schie-
mann et al., 2001; Schneider et al., 2001; Shulga-Morskaya
et al., 2004; Thompson et al., 2001). Furthermore, treatment of
mice with reagents that block binding of BAFF to BAFFR leads
to loss of most follicular cells, whereas transgenic elevation of
BAFF expression leads to increased numbers of B cells (Gross
et al., 2000, 2001; Mackay et al., 1999). Thus BAFF regulates
B cell survival, and the amount of BAFF determines the size of
the B cell compartment. Studies have shown that BAFFR signals
in part through the TRAF2 and TRAF3 E3 ligases, leading to
activation of the MAP 3-kinase NIK and IkB kinase 1 (IKK1).
This promotes the proteolytic processing of NF-kB2 (p100) into
p52, an NF-kB family transcription factor that translocates into
the nucleus and regulates gene expression (Rickert et al., 2011).
On mature B cells, the BCR is found in the form of surface-
bound immunoglobulin M (IgM) and IgD. These proteins are
both associated with the nonpolymorphic Iga and Igb (CD79a
and CD79b) transmembrane proteins, which are required for
BCR signal transduction (Kurosaki, 1999). Inducible loss of the
BCR or Iga results in the rapid death of all subsets of mature B
cells (Kraus et al., 2004; Lam et al., 1997). Furthermore, B cells
are also lost following deletion of a portion of the cytoplasmic
domain of Iga containing an immunoreceptor tyrosine-based
activation motif (ITAM), which is critical for signaling from the
BCR (Kraus et al., 2004). These results suggest that the BCR
delivers a signal required for the survival of B cells. Such a signal
could be generated either following low-affinity interactions of
the BCR with self-antigens, or by continuous low-level ‘‘tonic’’
BCR signaling in the absence of ligand engagement. Survival
of BCR-deficient B cells can be rescued by ectopic activation
of phosphatidylinositide-3 (PI3) kinase and this survival signal
may be mediated in part by Akt, which phosphorylates and
inactivates the FOXO1 transcription factor, a regulator of proap-
optotic genes. Taken together, these results suggest that the
BCR transduces a B cell survival signal via PI3 kinase, Akt, and
FOXO1 (Srinivasan et al., 2009). However, because BAFFR can
directly lead to PI3 kinase and Akt activation (Otipoby et al.,
2008; Patke et al., 2006; Woodland et al., 2008), it remains
unclear why B cell survival requires signals from both the BCR
and BAFFR.
Whereas the BCR delivers a survival signal in resting mature
B cells, antigen binding to the receptor promotes B cell activa-
tion, proliferation, and differentiation. Thus signaling from the
BCR can lead to two quite different outcomes. However theImmunity 38, 475–488, March 21, 2013 ª2013 Elsevier Inc. 475
 n
oiss
erpx
e
 kyS
DgI
2
DC
022B
MgI
5
DC
0
20
40
60
0
5
10
15
20
25
0
10
20
30
40
0
1
2
3
4
0
5
10
15
A
B
C
D
E
F G
Figure 1. Deletion of Syk Leads to the Loss of Most, but Not All, B Lineage Cells
Control (Sykfl/+;Rosa26MerCreMer/+, Sykfl/+RMCM) or conditional Syk-deficient mice (Sykfl/;Rosa26MerCreMer/+, Sykfl/RMCM) were treated with tamoxifen.
(A) The left panel shows a histogram of the amount of intracellular Syk protein in B or T cells from indicated mice 3 weeks after start of tamoxifen injections. The
right panel shows the mean (±SEM) fluorescence intensities of anti-Syk antibody, normalized to signal in T cells (dashed line) in mice of indicated genotype as
(legend continued on next page)
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BCR Is a Component of the BAFFR Signaling Pathwaymechanism underlying these differences is unknown. Binding of
antigen to the BCR leads to rapid phosphorylation of two tyro-
sines within the ITAMs of Iga and Igb, probably mediated by
Src-family kinases (Kurosaki, 1999). Subsequently, the tandem
phosphotyrosines on the Iga and Igb ITAMs serve as binding
sites for the tandem SH2 domains of the Syk tyrosine kinase,
leading to autophosphorylation and activation of the kinase
(Mo´csai et al., 2010). Studies in the chicken DT40 leukemic B
cell line have shown that loss of Syk blocks BCR-induced
calcium flux, suggesting that Syk is critical for the antigen-
induced activation signal from the BCR (Takata et al., 1994).
Deletion of the Syk gene in mice results in a partial block in B
cell development at the pre-BCR checkpoint and complete
arrest at the BCR checkpoint. Consequently, no mature B cells
develop at all, consistent with a key role for Syk in transducing
pre-BCR and BCR signals required for developmental pro-
gression (Cheng et al., 1995; Turner et al., 1997; Turner et al.,
1995). In view of these findings, it is possible that Syk may also
be important for the tonic BCR survival signal. Here we investi-
gated this possibility by studying the effect of inducible deletion
of Syk on B cell survival.
We found that deletion of Syk led to loss of follicular and MZ
B cells, which correlated with the inability of Syk-deficient B cells
to survive in response to BAFF. By using biochemical and
genetic rescue approaches, we demonstrated that Syk trans-
duces key BAFFR survival signals via the ERK and PI3 kinase
pathways. Surprisingly, we discovered that BAFF stimulated
rapid phosphorylation of Iga and Syk and that BAFF-induced
phosphorylation of Syk required the BCR. Thus we conclude
that the BAFFR and BCR signaling pathways are closely con-
nected and that rather than delivering an independent tonic
survival signal, the BCR and its associated Iga subunit may serve
as adaptor proteins in a BAFFR signaling pathways required for
B cell survival.
RESULTS
Loss of Syk Results in Loss of Most Mature B Cells
To investigate the potential role of Syk in transducing the BCR
tonic survival signal, we utilized a mouse strain in which Syk
could be inducibly deleted. This consisted of a conditional allelea function of time following tamoxifen injection. Note that the control mice start
treatment, and conditional Syk-deficient mice start with one allele, which is reduc
mice start with about half the amount of Syk protein compared to control mice.
(B) Flow cytometric analysis of bonemarrowB lineage cells (B220+CD19+ or B220
Numbers indicate percentages of cells in the marked gates.
(C) Graph of mean (±SEM) number of all B lineage cells (B220+CD19+), pro-B (
B (B220+CD19+IgDIgM+CD2+), and mature B (B220+CD19+IgD+) cells in the bon
determined using gates shown in (B).
(D) Flow cytometric analysis of splenic B lineage cells before and 5 weeks after t
(B220+CD93+) andmature (B220+CD93) B cells; right-hand panels show separati
(CD23IgM+). Numbers indicate percentages of cells in the marked gates.
(E) Graph of mean (±SEM) number of B cells (B220+), T cells (CD4+ or CD8+
CD93CD23IgM+), and transitional (B220+CD93+) B cells in the spleen of indica
gates shown in (D).
(F) Flow cytometric analysis of B cells (B220+CD19+) from the peritoneal cavity
indicate percentages of cells in the marked gates.
(G) Graph of mean (±SEM) number of B1a (B220+CD19+CD5+CD23), B1b (B220
cavity of indicated mice as a function of time following tamoxifen injection, deterof Syk in which exon 11 is flanked by loxP sites (Sykfl) and an
allele of ROSA26 (Rosa26MerCreMer) expressing a tamoxifen-
inducible MerCreMer fusion protein consisting of the Cre recom-
binase fused to two mouse estrogen receptor hormone-binding
domains (Zhang et al., 1996). We generated two mouse strains:
control (Sykfl/+Rosa26MerCreMer/+, Sykfl/+RMCM) or conditional
Syk-deficient mice (Sykfl/Rosa26MerCreMer/+, Sykfl/RMCM).
Both strains of mice expressed the Cre recombinase and had
one loxP-flanked allele of Syk but differed in the second Syk
allele, with the control mice having a wild-type allele (Syk+) and
the Syk-deficient mice having a nonfunctional deleted allele
(Syk). This allowed us to control for the activity of the recombi-
nase and any potential effect of deleting and recombining
genomic DNA. Treatment of conditional Syk-deficient mice
with tamoxifen resulted in the loss of Syk in virtually all B cells,
with the amount of Syk falling below detection by 10 days
following start of tamoxifen treatment (Figure 1A). In contrast,
treatment of control mice with tamoxifen resulted in loss of one
allele of Syk and thus protein amounts fell by about half.
Analysis of B lineage cells in these mice showed that loss of
Syk caused no change in the number of bonemarrow pro-B cells
but resulted in a rapid loss of bone marrow pre-B and immature
B cells and splenic transitional B cells (Figures 1B–1E), resem-
bling the phenotype of mice with a constitutive deficiency of
Syk, which show a developmental block at the pre-BCR check-
point and a block in BCR-driven positive selection of immature
B cells into the mature B cell compartment (Cheng et al., 1995;
Turner et al., 1995, 1997). Furthermore, we saw a loss of the
majority of marginal zone B cells and most (80%) follicular
B cells (Figures 1D and 1E). Most recirculating follicular B cells
were also lost from blood and lymph nodes (data not shown);
however, around 50%of control numbers ofmature recirculating
B cells remained in the bone marrow (Figures 1B and 1C). Lastly,
we examined B cells in the peritoneal cavity. In agreement with
the loss of follicular B cells in the spleen, we saw a loss of the
equivalent B2 cells. However B1 cells (both B1a and B1b) were
only partially reduced (Figures 1F and 1G). In contrast, the
number of T cells was unaffected by the inducible loss of Syk
(Figure 1E). Taken together, these results show that inducible
loss of Syk in an adult mouse resulted in B cell developmental
blocks in the bonemarrow at the pre-BCR and BCR checkpointswith two functional Syk alleles, which is reduced to one following tamoxifen
ed to no functional alleles following tamoxifen treatment. Hence the conditional
+CD19+IgD-) before and 5weeks after tamoxifen treatment from indicatedmice.
B220+CD19+IgDIgMCD2), pre-B (B220+CD19+IgDIgMCD2+), immature
e marrow of indicated mice as a function of time following tamoxifen injection,
amoxifen treatment from indicated mice. Left-hand panels identify transitional
on ofmature B cells into follicular B cells (CD23+IgM+) andmarginal zone B cells
), and follicular (FoB, B220+CD93CD23+IgM+), marginal zone (MZ, B220+
ted mice as a function of time following tamoxifen injection, determined using
before and 5 weeks after tamoxifen treatment from indicated mice. Numbers
+CD19+CD5CD23), and B2 (B220+CD19+CD5CD23+) cells in the peritoneal
mined using gates shown in (F). See also Figure S1.
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BCR Is a Component of the BAFFR Signaling Pathwayand caused the disappearance of most mature follicular and
marginal zone B cells, though not of B1 cells. It is unlikely that
this loss of B cells is a consequence simply of a block in B cell
development, because in the absence of input from the bone
marrow, mature B cells turn over with a half-life of around
4.5 months (Hao and Rajewsky, 2001), whereas loss of Syk
caused the disappearance of most mature B cells within
3 weeks.
We analyzed the characteristics of the surviving pool of
Syk-deficient B cells. Similar to control mature B cells, these
cells were largely nondividing, turned over at an even slower
rate and persisted for at least 8 weeks from the start of tamox-
ifen treatment (see Figures S1A and S1B available online;
Figure 1E). Phenotyping of cell surface markers showed that
these surviving cells most closely resembled follicular B cells,
being B220+CD19+IgM+IgD+CD23+CD21+MHCclassII+CD40+
CD1dCD93 (Figure S1C). However, they expressed much
more surface IgM and somewhat more CD19. It is unlikely that
this represents the selective survival of a subset of B cells with
high amounts of IgM, because this increase in IgM could be
seen already 4 days after the start of tamoxifen treatment, before
any decrease in B cell numbers (data not shown). Rather, the loss
of Syk may cause a change in the recycling of IgM between the
cell surface and the cytoplasm.
Requirement for Syk in B Cell Survival Is Intrinsic
to the B Cell Lineage
We next investigated whether the requirement for Syk in B cell
survival is cell intrinsic. This was an important issue because
Syk is expressed in most hematopoietic lineages and the
Rosa26MerCreMer allele is expressed ubiquitously, and thus loss
of Syk could affect B cell survival indirectly through other cell
types. We reconstituted the hematopoietic system of irradiated
mice with a mixture of wild-type (Ly5.1+) and either control or
conditional Syk-deficient bone marrow cells (Ly5.2+). Eight
weeks later, once the mice were fully reconstituted, they were
treated with tamoxifen and B cell numbers were followed
for 8 weeks. Results showed that there was a selective loss of
B cells that had lost Syk, even in the presence of wild-type B cells
(Figure S1D). Once again, the small surviving population of
Syk-deficient B cells most closely resembled follicular B cells,
except for elevated amounts of IgM (Figure S1E). In a second
approach, we bred the conditional Syk allele to mice expressing
the tamoxifen-inducible Cre recombinase Cre-ERT2 under the
control of the B lineage-specificCd79a promoter (Cd79aCreERT2).
As before, we found that 3 weeks after the start of tamoxifen
treatment pre-B and immature B cells were lost from the bone
marrow, all transitional and marginal zone B cells and around
80% of follicular B cells were lost from the spleen, whereas
most B1 cells persisted in the peritoneum (Figures S1F–S1I).
The surviving Syk-deficient B cells expressed the charac-
teristically high amounts of IgM described before (Figures S1F
and S1G). Taken together these results demonstrate that
the requirement for Syk in B cell survival is cell autonomous
and intrinsic to the B lineage itself. This loss of B cells after dele-
tion of Syk is similar to that reported in mice in which the BCR is
deleted (Kraus et al., 2004; Lam et al., 1997), consistent with the
hypothesis that Syk transduces the tonic BCR signal required for
cell survival.478 Immunity 38, 475–488, March 21, 2013 ª2013 Elsevier Inc.Syk-Deficient B Cells Are Unable to Survive in Response
to BAFF
To investigate the mechanism by which Syk contributes to B cell
survival, we examined the ability of Syk-deficient B cells to
survive in vitro in response to BAFF, a cytokine critically required
for the survival of follicular and marginal zone B cells (Mackay
et al., 2010).We found that Syk-deficient B cells were very defec-
tive in their ability to survive in response to BAFF (Figure 2A;
Figure S2A). This defect was not due to the phenotype of an
atypical subtype of B cells that survives in the absence of Syk,
because a survival defect in response to BAFF could be seen
as soon as Syk protein starts to be lost from the cells. For
example, 7 days after the start of tamoxifen the number of B cells
had not yet changed greatly, but most Syk had been lost and the
B cells were already substantially impaired in their ability to
respond to BAFF (Figure 2A). By 10 days following tamoxifen
treatment, Syk-deficient B cells showed almost no BAFF-
induced survival (Figure 2A), yet gene expression analysis
showed only very small differences in expression between
mutant and control B cells (4 differentially expressed genes out
of 21,000) supporting the view that the Syk-deficient B cells
were not an unusual subset of B cells (Figure S2B). In view of
the importance of BAFF for B cell survival, it is thus very likely
that the loss of follicular andmarginal zone B cells in the absence
of Syk is due to an inability of the cells to respond to BAFF. In
agreement with this hypothesis, we note that B1 cells do not
require BAFF for survival (Mackay et al., 2010), and this is the
subset that is least dependent on Syk for its survival.
Loss of Syk-Deficient B Cells Is Not Due to Reduced
Expression of BAFFR
It has been proposed that signaling through the BCR leads to an
increase in expression of BAFFR (Smith and Cancro, 2003). Thus
one possible reason for the inability of Syk-deficient B cells to
survive in response to BAFF is that Syk normally transduces
BCR signals required to maintain BAFFR expression. However,
flow cytometric analysis showed only a small decrease in BAFFR
in Syk-deficient B cells to 60% of control amounts (Figure 2B).
Nevertheless, to evaluate whether this decrease affected
BAFF-induced survival, we established a retroviral-based com-
plementation procedure to ectopically increase BAFFR ex-
pression. Initially, we tested the procedure by using a retroviral
vector expressing Syk and GFP (as a marker of infection) to
infect bone marrow cells from control (Sykfl/+RMCM) or con-
ditional Syk-deficient mice (Sykfl/-RMCM), which were used to
reconstitute irradiated mice. Once reconstitution was complete
(around 8 weeks posttransplant), the chimeric mice were treated
with tamoxifen and analyzed 6 weeks later. B cells from the
conditional Syk-deficient mice infected with the retrovirus
(GFP+) expressed about 40% the amount of Syk found in control
B cells (Figure S2C). This amount of expression was sufficient
to allow enhanced survival compared to uninfected (GFP)
Syk-deficient B cells, as seen by a higher ratio of GFP+ to
GFP conditional Syk-deficient B cells compared to the ratio
of GFP+ to GFP T cells in the same animal (Figures S2D–S2F).
Ectopic expression of Syk in Syk-deficient B cells also
corrected the surface IgM amounts, reducing them to levels
similar to those seen in control B cells, and partially rescued
the defect in BAFF-induced survival (Figures S2G and S2H).
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Figure 2. Syk-Deficient B Cells Are Unresponsive to BAFF, a Defect that Is Not Reversed by Ectopic Expression of BAFFR
(A) Graph showing mean (±SEM) number of B cells of the indicated genotypes surviving after 4 days culture in the absence (-) or presence of BAFF, normalized to
the number of surviving control B cells in presence of BAFF. Cells were harvested 7–21 days after tamoxifen injection, as indicated.
(B) Histograms of BAFFR amounts on splenic B cells (IgM+) from mice of the indicated genotypes treated with tamoxifen 21 days earlier, and on T cells from
Sykfl/RMCM mice as a negative control. Graph shows mean (±SEM) BAFFR amounts on B and T cells from the indicated mice.
(C and D) Irradiated mice were reconstituted with Sykfl/+RMCM or Sykfl/RMCM bone-marrow cells, previously infected with a retrovirus expressing BAFFR and
the humanCD2 extracellular and transmembrane domains (huCD2), treated with tamoxifen and analyzed 6weeks later. Flow cytometric analysis of donor splenic
B and T cells from the chimeras: dot plot of CD19 and huCD2 expression (C) and histograms of huCD2 expression (D). Numbers indicate percentage of cells falling
into quadrants.
(E) Graph of mean (±SEM) ratio of percentage of huCD2+ B cells to percentage of huCD2+ T cells in the spleens of mice of the indicated genotypes (ns, not
significantly different). Increase in this ratio would imply a survival advantage for the transduced B cells.
(F) Histograms of surface IgM amounts on donor splenic B cells from chimeras described in (C) subdivided according to huCD2 expression, as a marker of
retroviral infection.
(G) Graph showing mean (±SEM) number of donor B cells from chimeras reconstituted with the indicated genotypes surviving after 4 days culture in the absence
(-) or presence of BAFF. Cells were subdivided according to expression of huCD2. Numbers are normalized to the number of surviving control huCD2 B cells in
presence of BAFF. See also Figure S2.
Immunity
BCR Is a Component of the BAFFR Signaling Pathway
Immunity 38, 475–488, March 21, 2013 ª2013 Elsevier Inc. 479
Immunity
BCR Is a Component of the BAFFR Signaling PathwayIn contrast, retroviral-driven Syk expression in control B cells did
not provide a selective survival advantage, presumably because
the amount of Syk expressed from the endogenous Syk locus
was not limiting for survival and did not change amounts of
IgM or affect BAFF-induced cell survival (Figures S2D–S2H).
We also used the same retroviral transduction system to
ectopically express a kinase dead form of Syk in both control
and conditional Syk-deficient B cells. Following deletion of the
endogenous Syk gene, this mutant Syk protein was unable to
confer a selective in vivo survival advantage to B cells that had
lost expression of endogenous Syk, did not normalize surface
IgM amounts and did not rescue the BAFF-induced survival
defect (Figures S2C–S2H). Taken together these results show
that retroviral gene transduction of Syk into bone marrow cells
from conditional Syk-deficient mice rescues B cell survival and
thus this system can be used to test the ability of other genes
to rescue survival of Syk-deficient B cells. We also conclude
that the kinase activity of Syk is essential for its function in medi-
ating B cell survival.
In order to determine whether the reduced expression of
BAFFR on Syk-deficient B cells was the cause of their failure
to survive in response to BAFF, we used a retroviral vector ex-
pressingBAFFRanda truncated formof humanCD2 (as amarker
of infection) to increase receptor amounts on both control and
conditional Syk-deficient B cells. We found that increased
expression of BAFFR did not promote increased survival of
Syk-deficient B cells in vivo, had no effect on the increased
amounts of surface IgM and did not rescue the defect in
BAFF-induced survival in vitro (Figures 2C–2G). In contrast,
increased expression of BAFFR on control B cells increased
survival in response to BAFF in vitro, demonstrating that the
increased amounts of the receptor were functional. Thus, the
reduced expression of BAFFR on Syk-deficient B cells is unlikely
to account for their failure to survive.
Reduced Survival of Syk-Deficient B Cells Is Not Caused
by Defects in the NF-kB2 p100 Pathway
A critical signaling pathway from BAFFR required for B cell
survival involves phosphorylation of NF-kB2 p100 by IKK1, its
processing into p52 and subsequent nuclear translocation of
the p52 transcription factor (Rickert et al., 2011). It has been
proposed that the BCR tonic signal through Syk is required for
the synthesis of p100, which is then used in an IKK1 signaling
pathway emanating from BAFFR (Stadanlick et al., 2008). Such
a pathway could potentially explain the dual requirement for
both the BCR and BAFFR for B cell survival. We examined this
possibility by measuring amounts of both p100 and p52 in
control and mutant B cells before and after BAFF stimulation.
For this and subsequent biochemical studies, we used B cells
from mice treated with tamoxifen 10 days earlier because by
this time point there was no detectable Syk expression, most
of the cell death had not yet occurred and in their transcriptome
the cells still closely resembled control B cells (Figure S2B). We
found that unstimulated Syk-deficient B cells had slightly lower
p100 amounts than control B cells, but unaltered total amounts
of p52+p100 protein (Figures 3A and 3B) or NF-kB2 messenger
RNA (mRNA) (data not shown). However, in response to BAFF
the amounts of p100 dropped and the ratio of p52/p100 rose
in both control and mutant B cells, suggesting that the p100480 Immunity 38, 475–488, March 21, 2013 ª2013 Elsevier Inc.pathway was functioning in the absence of Syk (Figures 3A
and 3B). Nevertheless, to test this hypothesis genetically, we
used the retroviral complementation system to ectopically
express p100 in both control and Syk-deficient B cells (Fig-
ure 3C). We found that increased expression of p100 did not
rescue in vivo survival of Syk-deficient B cells, did not affect
the increased amounts of surface IgM and did not rescue
BAFF-dependent survival in vitro (Figures 3D–3H). In contrast,
control B cells overexpressing p100 survived much better
in vitro in response to BAFF compared to uninfected cells,
demonstrating that the ectopically expressed p100 was bio-
logically functional.
To explore this pathway further, we made use of a mutant
form of p100 (p100DC), which is converted more efficiently to
p52 (Figure S3A) (Liao and Sun, 2003). Once again the retroviral
complementation assay showed that ectopic expression of
p100DCwas not able to increase survival of Syk-deficient B cells
in vivo, normalize IgM amounts, or rescue the defect in BAFF-
induced survival in vivo (Figures S3B–S3E). Thus we conclude
that the failure of Syk-deficient B cells to survive is not due to
a defect in the p100 pathway.
Normal Expression of Bcl-2-Family Proteins
in Syk-Deficient B Cells
Stimulation of B cells with BAFF leads to the upregulation of
several antiapoptotic members of the Bcl-2-family of proteins,
including Bcl-2, Bcl-xL, Mcl1, and A1, and to the downregulation
of the proapoptotic Bim and Bad proteins (Rickert et al., 2011).
To investigate whether dysregulation of these proteins contrib-
uted to the survival defect of Syk-deficient B cells, we initially
measured mRNA amounts for Bcl-2-family proteins (Table S1).
We detected no significant changes in any of these, except for
the genes encoding A1, which were expressed at around 60%
of the amount in control B cells. To explore this further, we immu-
noblotted cell lysates from control and mutant B cells and
probed for several Bcl-2-family members, including Bcl-2, Bcl-
xL, Mcl1, A1, Bim, Bid, Bad, and Bax. We saw no consistent
differences between mutant and control B cells in the amounts
of any of these proteins, including A1 (Figures S3F and S3G),
suggesting that reduced survival of Syk-deficient B cells is not
caused by dysregulated expression of Bcl-2-family proteins,
though we cannot rule out that there may be alterations in post-
translational modification of these proteins that contribute to
increased cell death. Because the expression of many of these
proteins is under the control of NF-kB transcription factors
(Mackay et al., 2010), these results further support the conclu-
sion that the reduced survival of Syk-deficient B cells is unlikely
to be due to defects in NF-kB pathways.
Ectopic Activation of the ERKPathway Partially Rescues
Survival of Syk-Deficient B Cells
Another critical pathway controlling B cell survival is one leading
to the activation of the ERK MAP kinases (Craxton et al., 2005).
Because Syk transduces BCR signals to the activation of ERK
following crosslinking of the BCR, it is possible that it may also
transduce the tonic BCR survival signal to ERK activation.
Indeed, we found that BAFF-induced phosphorylation of ERK,
a hallmark of its activation, was reduced in Syk-deficient B cells
(Figures 4A–4D). To investigate whether this defect may
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Figure 3. Ectopic Expression of p100 Does Not Rescue Defect in BAFF-Induced Survival of Syk-Deficient B Cells
(A) Immunoblot of total cell extracts from splenic B cells of the indicated genotypes that had been cultured for 16h in the absence (-) or presence (+) of BAFF,
probed with antibodies to NFkB2 (to detect p100 and p52), Syk and tubulin.
(B) Graphs ofmean (±SEM) amounts of p100, p52+p100, and ratio of p52/p100 from splenic B cells as described in (A). p100 and p52 amounts were normalized to
tubulin and then p100, p52+p100, and the ratio of p52/p100 were normalized to control B cells cultured without BAFF.
(C) Histogram shows amounts of human p100 (hu-p100) in B cells from radiation chimeras reconstituted with bone marrow of Sykfl/+RMCM mice infected with
empty vector (EV) or retrovirus expressing hu-p100; both vectors express GFP. Cells were subdivided according to GFP expression.
(D and E) Flow cytometric analysis of donor splenic B and T cells from radiation chimeras reconstituted with bone marrow of Sykfl/+RMCM or Sykfl/RMCMmice
infected with retrovirus expressing hu-p100 and GFP, then treated with tamoxifen to induce deletion of Syk. Numbers indicate percentage of cells falling into
quadrants.
(F) Graph ofmean (±SEM) ratio of the percentage of donor B cells that were GFP+ to the percentage of donor T cells that were GFP+ in the spleens of chimeric mice
reconstituted with bone marrow of the indicated genotypes (ns, not significantly different).
(G) Histograms of surface IgM amounts on donor splenic B cells from chimeras described in (B) subdivided according to GFP expression, as amarker of retroviral
infection.
(H) Graph showing mean (±SEM) number of donor B cells from chimeras reconstituted with the indicated genotypes surviving after 4 days culture in the absence
(-) or presence of BAFF. Cells were subdivided according to expression of GFP. Numbers are normalized to the number of surviving control GFP B cells in
presence of BAFF. See also Figure S3 and Table S1.
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Figure 4. Ectopic Expression of Constitutively Active MEK1 (caMEK1) Rescues In Vivo Survival Defect of Syk-Deficient B Cells
(A–D) Splenic B cells of the indicted genotypes were cultured (A and B) for 16 hr in the absence (-) or presence (+) of BAFF or (C and D) for the indicated times.
(A and C) Immunoblots of total cell extracts probed with antibodies to pERK, ERK2, and Syk. (B and D) Graphs of mean (±SEM) ratio of pERK to ERK2 in splenic
B cells cultured and analyzed as described in (A) and (C), respectively. Ratios were normalized to control B cells cultured without BAFF.
(E–H) Radiation chimeras were reconstituted with bone marrow of Sykfl/+RMCM or Sykfl/RMCM mice infected with retrovirus expressing caMEK1 and huCD2,
then treated with tamoxifen to induce deletion of Syk. (E) Flow cytometric analysis of huCD2 expression in donor splenic B and T cells from radiation chimeras.
(legend continued on next page)
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Immunity
BCR Is a Component of the BAFFR Signaling Pathwaycontribute to the reduced survival of Syk-deficient B cells, we
used the retroviral complementation system to ectopically
express a constitutively active MEK1 kinase (caMEK1) a direct
activator of the ERK kinases, in both control and mutant B cells.
We found that expression of caMEK1 selectively increased
survival of Syk-deficient B cells in vivo, while having no effect
on control B cells (Figures 4E and 4F). However it did not
normalize IgM amounts and did not rescue the defective
BAFF-induced survival in vitro (Figures 4G and 4H). The expres-
sion of caMEK1 did not lead to aberrant activation of the B cells
as shown by unaltered cell size and expression of the activation
markers CD69, CD86, and I-A (Figure S4). These results suggest
that Syk transduces BAFFR signals to ERK activation and that
reduced ERK activation in Syk-deficient B cells may partially
account for their decreased survival in vivo.
Activation of the PI3 Kinase Pathway Partially Rescues
Survival of Syk-Deficient B Cells
A critical pathway controlling survival of many cell types is the
PI3 kinase pathway, leading to the production of phosphatidyli-
nositide-3,4,5-trisphosphate (PIP3). Previous work has shown
that the death of B cells that have lost the BCR can be reversed
by ectopic activation of the PI3 kinase pathway, leading to the
proposal that the BCR survival signal uses this pathway (Sriniva-
san et al., 2009). To investigate whether Syk may transduce
such a signal, we examined BAFF-induced phosphorylation of
Akt as a surrogate for the production of PIP3, in both mutant
and control B cells. We found that the amount of phosphorylated
Akt was reduced in Syk-deficient B cells both before and after
stimulation with BAFF (Figure 5A), consistent with Syk trans-
ducing both the BCR survival signal and a BAFFR signal leading
to activation of PI3 kinase.
To determine whether the reduced activation of PI3 kinase
contributes to the survival defect of Syk-deficient B cells, we
generated radiation chimeras reconstituted with bone marrow
from mice carrying Rosa26MerCreMer and a conditional allele of
Syk, Pten, or both. PTEN is a phosphatase that converts PIP3
to phosphatidylinositide-4,5-bisphosphate, thereby directly
counteracting the activity of PI3 kinases. Deletion of Pten will
cause a rise in cellular PIP3 amount, and thus if loss of Syk-defi-
cient B cells is due in part to reduced PI3 kinase activity, deletion
of Pten should rescue survival. This is indeed what we observed:
loss of PTEN in Syk-deficient B cells resulted in increased
numbers of both follicular and marginal zone B cells and partially
rescued BAFF-induced survival of Syk-deficient B cells (Figures
5B–5D). Thuswe conclude that Syk transduces signals to the PI3
kinase pathway, which are in part required for B cell survival.
PDK1 Is Essential for B Cell Survival and Response
to BAFF
The PI3 kinase pathway contributes to cell survival in part
through the activation of Akt and subsequent phosphorylation
of the FOXO transcription factors (Zhang et al., 2011). The acti-(F) Graph ofmean (±SEM) ratio of the percentage of donor B cells that were huCD2
mice reconstituted with bone marrow of the indicated genotypes. (G) Expression o
Graph showingmean (±SEM) number of donor B cells from chimeras reconstituted
presence of BAFF. Cells were subdivided according to expression of huCD2. N
presence of BAFF. See also Figure S4.vation of Akt requires the prior PIP3-dependent activation of
the PDK1 kinase (encoded by the Pdpk1 gene) and subsequent
phosphorylation of Akt on Thr308 by PDK1 and on Ser473 by
mTORC2 or other kinases (Bozulic and Hemmings, 2009). If
the requirement for PI3 kinase activation for B cell survival
requires Akt activation, then B cell survival may also be depen-
dent on PDK1. To address this possibility, we used bonemarrow
from mice with a conditional allele of Pdpk1 (Pdpk1fl) crossed to
a tamoxifen-inducible Cre recombinase expressed from the
ROSA26 locus (Rosa26Cre-ERT2/+, RCE) to reconstitute irradiated
mice. Analysis showed that 6 weeks after tamoxifen treatment
there was a small reduction in pre-B and immature B cells in
the bone marrow, but a large decrease in mature recirculating
B cells in the marrow, as well as transitional, follicular, and
marginal zone B cells in the spleen (Figures 6A and 6B). Further-
more, the surviving PDK1-deficient B cells had elevated
amounts of IgM, and were very defective in their ability to survive
in response to BAFF in vitro (Figures 6C and 6D). Thus PDK1
is also essential for the survival of mature B cells and for
responses to BAFF, and the phenotype of PDK1-deficient
B cells is similar to that of Syk-deficient cells, consistent with
the hypothesis that Syk transduces survival signals through PI3
kinase and PDK1.
BAFFR Signals through the BCR
The previous results have shown that Syk transduces signals
critical for survival of B cells in vivo and BAFF-induced survival
in vitro, and it does so in part through ERK and PI3 kinase-
PDK1 pathways. However it is unclear from this whether Syk
transduces a tonic BCR signal that is required in conjunction
with BAFFR signals for cell survival, or whether it might trans-
duce BAFFR signals directly. The latter possibility is suggested
by the observation that BAFFR-induced activation of ERK and
PI3 kinase pathways is defective in Syk-deficient cells. To inves-
tigate this further, we measured BAFF-induced phosphorylation
of Syk, a hallmark of its activation. We were able to detect rapid
activation of Syk in response to BAFF, peaking at 5 min (Figures
7A and 7B). The increase in Syk phosphorylation in response to
BAFF was smaller than that seen following stimulation of the
BCR with an anti-IgM antibody (2.5-fold compared to 10-fold);
nonetheless, the increase was reproducible and significant.
Syk has been reported to transduce signals from different
classes of receptors, including antigen receptors, integrins,
and C-type lectins (Mo´csai et al., 2010). Despite this variety, in
all cases, the activation process involves binding of the SH2
domains of Syk to phosphorylated tyrosines within ITAM-like
motifs. In view of this, we postulated that the activation of Syk
downstream of BAFFR is also likely to involve a phosphorylated
ITAM, with the most obvious candidates in a B cell being the Iga
and Igb proteins. Indeed, we detected phosphorylation of Iga in
response to BAFF, peaking around 5 min, similar to the kinetics
observed for the phosphorylation of Syk (Figures 7A and 7B).
Once again, the increase in Iga phosphorylation was smaller+ to the percentage of donor T cells that were huCD2+ in the spleens of chimeric
f IgM and huCD2 on donor-derived splenic B cells from radiation chimeras. (H)
with the indicated genotypes surviving after 4 days culture in the absence (-) or
umbers are normalized to the number of surviving control huCD2 B cells in
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Figure 5. Deletion of Pten Rescues In Vivo and In Vitro Survival Defect of Syk-Deficient B Cells
(A) Splenic B cells of the indicated genotypes were cultured for 16 hr in the absence (-) or presence (+) of BAFF. Immunoblots of total cell extracts were probed
with antibodies to pS473-Akt (pAkt) and Akt. Graph shows mean (±SEM) ratio of pAkt to Akt in splenic B cells cultured with or without BAFF. Ratios were
normalized to control B cells cultured without BAFF.
(B–D) Radiation chimeras were generated by reconstituting irradiated Rag1-deficient mice with bone marrow frommice carrying conditional alleles of Syk, Pten,
or both; all contained the Rosa26MerCreMer allele. Six weeks after reconstitution, chimeras were treated with tamoxifen and analyzed 3 weeks later. (B) Flow
cytometric analysis of donor-derived splenic mature B cells (B220+CD93) from chimeras reconstituted with marrow of the indicated genotypes. Numbers
indicate percentage of B cells in the follicular (FoB, IgM+CD23+) andmarginal zone (IgM+CD23) compartments. (C) Mean (±SEM) numbers of all B cells, FoB, and
MZ cells in the spleens of the chimeras. (D) Graph showingmean (±SEM) number of B cells of the indicated genotypes surviving after 4 days culture in the absence
(-) or presence of BAFF, normalized to the number of surviving control B cells in presence of BAFF. Statistically significant differences are shown only for
comparisons between Syk-deficient cells and cells deficient in both Syk and Pten.
Immunity
BCR Is a Component of the BAFFR Signaling Pathwaythan that seen following BCR stimulation but was nonetheless
reproducible and significant.
These results suggested that BAFFR signaling induces Iga
phosphorylation, which in turn leads to Syk activation. If this
hypothesis is correct, the prediction would be that B cells that
had lost the BCR would also lose BAFF-induced Syk phosphor-
ylation. To investigate this, we made use of the B1-8f allele
(IghB1-8f/+) in which a rearranged VDJ segment flanked by loxP
sites is placed in the Ig heavy-chain locus in such a way that
the B cells predominantly express this one prerearranged
heavy chain (Lam et al., 1997). Cre-induced deletion of the VDJ
segment results in the loss of Igm heavy chain expression and
the associated Ig light chains and Iga and Igb proteins are no484 Immunity 38, 475–488, March 21, 2013 ª2013 Elsevier Inc.longer transported to the cell surface. We generated mice con-
taining both the IghB1-8f/+ allele and the tamoxifen-inducible
Rosa26MerCreMer allele, and treated adult mice with tamoxifen.
As expected, this resulted in rapid loss of cell-surface BCR
from many, though not all B cells. We purified IgM B cells
from these mice and measured phosphorylation of Syk in
response to BAFF compared to IgM+ B cells from control mice.
Whereas IgM+ B cells again showed clear induction of Syk
phosphorylation, this was largely absent in IgMB cells, demon-
strating that the BCR was required for BAFF-induced Syk acti-
vation (Figures 7C and 7D). Furthermore, we examined the
consequence of loss of BCR on BAFF-induced survival. We
found that, in contrast to IgM+ B cells, IgM B cells were unable
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Figure 6. Deletion of PDK1 Leads to the
Loss of Most B Lineage Cells
Radiation chimeras reconstituted with bone
marrow from mice carrying a tamoxifen-inducible
Cre (Rosa26Cre-ERT2/+, RCE) and either wild-type or
conditional alleles of the Pdpk1 gene (Pdpk1+/+ or
Pdpk1fl/fl), which codes for the PDK1 protein, were
treated with tamoxifen and analyzed 6 weeks later.
(A) Graph of mean (±SEM) number of all B lineage
cells, pro-B, pre-B, immature B (Imm), and mature
(Mat) B cells in the bone marrow of indicated
chimeric mice. Cell populations are identified as in
Figures 1B and 1C.
(B) Graph of mean (±SEM) number of all B lineage
cells, follicular (FoB), marginal zone (MZ), and
transitional (Tr) B cells in the spleen of indicated
chimeric mice. Cell populations are identified as in
Figures 1D and 1E.
(C) Flow cytometric analysis of IgM expression on the surface of splenic B cells from chimeric mice.
(D) Graph showingmean (±SEM) number of B cells of the indicated genotypes surviving after 4 days culture in the absence (-) or presence of BAFF, normalized to
the number of surviving control B cells in presence of BAFF.
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BCR Is a Component of the BAFFR Signaling Pathwayto survive in response to BAFF (Figure 7E). Phosphorylation of
Iga and Igb and subsequent Syk activation following antigen
binding to the BCR may be mediated by Src-family kinases
(SFKs). Thus we hypothesized that SFKs may also be required
for BAFF-induced Syk activation. In agreement with this, treat-
ment of B cells with PP1, a SFK inhibitor, resulted in reduced
BAFF-induced Syk phosphorylation (Figures S5A and S5B).
Furthermore BAFF-induced B cell survival was inhibited by
PP1 and two other SFK inhibitors: PP2 and Src-I (Figure S5C).
Taken together, these results show that BAFFR signaling leads
to Syk activation via the BCR, potentially through SFK-mediated
phosphorylation of Iga, and suggest that this pathway may be
required for BAFF-mediated B cell survival (Figure 7F).
DISCUSSION
Inducible elimination of Syk or of its kinase activity leads to the
loss of most follicular and MZ B cells, while sparing the majority
of B1 cells. This disappearance of B cells is accompanied by loss
of responsiveness to BAFF, which likely accounts for the selec-
tive loss of follicular and MZ B cells compared to B1 cells,
because a very similar phenotype is seen in mice deficient in
BAFF or BAFFR (Mackay et al., 2010). This similarity also
supports our proposal that Syk transduces survival signals
from BAFFR. It is unlikely that this unresponsiveness to BAFF
is simply the result of selective survival of a subset of B cells
that cannot respond to BAFF, because the decrease in BAFF-
induced survival parallels the loss of Syk and is seen before
any substantial decrease in B cell numbers. Nonetheless, we
note that a small number of follicular B cells persist in mice
deficient in BAFF or BAFFR, particularly following an inducible
inactivation of BAFFR (Keren et al., 2011), similar to that seen
in the absence of Syk, pointing to the existence of BAFF- and
Syk-independent survival pathways for a minority of follicular
B cells.
Given the central role for Syk in transducing BCR signals
following antigen binding, we had expected that loss of Syk
would lead to a phenotype similar to that seen following removal
of the BCR frommature B cells. While the two genetic alterationsare similar in terms of leading to loss of most follicular and MZ
B cells, they are clearly distinct in their effects on B1 cells, which
are largely unaffected by loss of Syk, but disappear following
deletion of the BCR (Lam et al., 1997). Furthermore, a small
number of Syk-deficient B cells persist for many weeks in the
animal, whereas B cells without a BCR are short-lived (Kraus
et al., 2004). These differences suggest that the BCR survival
signal is transduced partly through Syk and partly through other
pathways.
Analysis of survival pathways downstream of Syk showed that
BAFF-induced activation of ERK and Akt is decreased in the
absence of Syk, and genetic rescue experiments showed that
the survival of Syk-deficient B cells could be enhanced by
ectopic expression of caMEK1 or by deletion of PTEN. More-
over, loss of PDK1 also leads to the disappearance of most
follicular and MZ B cells. Taken together, these results suggest
that Syk transduces key survival signals through the ERK and
PI3 kinase-PDK1 pathways. In contrast, our results do not
support an important role for Syk-mediated regulation of the
amounts of either BAFFR or NF-kB2 p100 in B cell survival.
Furthermore, the largely normal BAFF-induced regulation of
the p100 pathway in Syk-deficient B cells demonstrates that
this pathway alone is unable to sustain BAFF-dependent B cell
survival.
As with Syk-deficient B cells, the death of BCR-deficient
B cells could be rescued by deletion of PTEN consistent with
the possibility that the BCR survival signal is transduced at least
in part through Syk and PI3 kinase (Srinivasan et al., 2009). In
contrast, caMEK1 did not rescue survival of cells that had lost
the BCR. The reasons for this difference from Syk-deficient
B cells are not known, but one possibility is that Syk may also
transduce survival signals independently of the BCR, and that
these may be transduced via the ERK pathway. Alternatively,
the difference could be due to use of different Cre drivers. In
our studies we used the Rosa26MerCreMer allele, which induces
deletion throughout the mature B cell compartment, whereas
Kraus et al. used CD21-Cre, which starts to delete within
transitional B cells (Kraus et al., 2004). It may be that the survival
pathways used in recently matured B cells are different to thoseImmunity 38, 475–488, March 21, 2013 ª2013 Elsevier Inc. 485
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Figure 7. BCR-Dependent BAFF-Induced
Phosphorylation of Syk and Iga in B Cells
(A) Immunoblots of total cell extracts from splenic
B cells stimulated with anti-IgM or BAFF for the
indicated times, probed with antibodies to phos-
phorylated Syk (pSyk), Syk, phosphorylated Iga
(pIga), and Iga. Two different exposures of the
same blots are shown for the pSyk and pIga to
show the different magnitudes of the BAFF and
anti-IgM responses.
(B) Graphs show the mean (±SEM) amounts of
pSyk or pIga in B cells stimulated with anti-IgM or
BAFF. The amounts of phosphoproteins were
normalized to the amount of Syk or Iga and further
normalized to the signal in unstimulated cells at
time = 0.
(C) Immunoblot of total cell extracts from splenic
B cells (either IgM+ or IgM) stimulated with BAFF
for the indicated times, probed with antibodies to
pSyk and Syk. IgM+ and IgM B cells were purified
from Rag1/ radiation chimeras reconstituted
with bone marrow from IghB1-8f/+Tg(Em-BclxL) and
IghB1-8f/+Tg(Em-BclxL)RMCM mice respectively,
that had been treated with tamoxifen 13–18 days
earlier.
(D) Graph of mean (±SEM) amounts of pSyk in IgM+
and IgM B cells determined as in (C), normalized
to amounts of Syk and to the signal in IgM+ B cells
at time = 0.
(E) Graph showing mean (±SEM) number of IgM+ or
IgM B cells surviving after 4 days culture in the
absence (-) or presence of BAFF, normalized to
the number of surviving IgM+ B cells in presence of
BAFF. IgM+ and IgM B cells were purified from
IghB1-8f/+ and IghB1-8f/+RMCM mice respectively,
that had been treated with tamoxifen 6 days earlier.
(F) Proposed signaling pathways from BAFFR
and BCR controlling B cell survival, showing
BAFFR-induced phosphorylation of Iga and acti-
vation of Syk via the BCR. As discussed in the text
and indicated by question marks, it is unclear
whether BAFFR-induced phosphorylation of Iga
occurs via NIK or IKK1 or if the signal is indepen-
dent of these kinases. See also Figure S5.
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BCR Is a Component of the BAFFR Signaling Pathwayused by the bulk of the mature B cells, with a different depen-
dence on the ERK pathway.
We note that both Syk- and BCR-deficient B cells whose
survival has been rescued by ectopic activation of the PI3 kinase
pathway remain dependent on BAFF for in vitro survival (Fig-
ure 5D; Srinivasan et al., 2009). These observations support
a model in which BAFFR delivers some critical survival signals486 Immunity 38, 475–488, March 21, 2013 ª2013 Elsevier Inc.independent of the BCR, Syk, and PI3
kinase; these could be through the IKK1-
p100 pathway.
Most unexpectedly, our results show
that BAFFR signaling leads to phosphory-
lation of Iga and Syk and that the phos-
phorylation of Syk is dependent on the
BCR, supporting our proposed model
that survival signals from BAFFR are
transduced via the BCR complex to the
activation of Syk. Syk transduces signalsdownstream of many receptors, including antigen receptors,
C-type lectins, and integrins, and in most cases Syk activa-
tion requires binding of the kinase to a phosphorylated ITAM
(Mo´csai et al., 2010). Our data suggest that in the case of BAFFR
the activation of Syk depends on the phosphorylation of Iga
and possibly Igb, though we cannot exclude that other ITAM-
bearing molecules may be involved. It remains unknown how
Immunity
BCR Is a Component of the BAFFR Signaling Pathwaysignaling from BAFFR leads to phosphorylation of Iga, but it may
be via SFKs. This is supported by our observation that inhibition
of SFKs leads to reduced BAFF-induced phosphorylation of
Syk and B cell survival. It is also possible that the signal from
BAFFR to the BCR goes through the NIK and/or IKK1 kinases,
though we note that NIK activation is induced more slowly by
BAFF than the phosphorylation of Syk, making this less likely.
Previous studies had shown that the BCR and its associated
Iga subunit were essential for the survival of mature B cells,
and these observations led to the suggestion that the BCR
may transduce survival signals either following low-affinity inter-
actions of the BCRwith self-antigens, or by continuous low-level
tonic BCR signaling in the absence of ligand engagement (Kraus
et al., 2004; Lam et al., 1997). However, our current results
suggest an alternative interpretation. We propose instead that
the requirement for the BCR and Iga in B cell survival may be
due to a function for these proteins as critical adapters in
a BAFFR signaling pathway leading to the activation of Syk
and hence to the activation of ERK and PI3 kinase pathways.
Based on our data we cannot exclude the possibility that the
BCR delivers a stand-alone survival signal; however, we note
that in contrast to our proposal, such a model does not explain
why BAFFR transduces signals via the BCR to the activation of
Syk, ERK, and Akt.
EXPERIMENTAL PROCEDURES
For an extended description of experimental procedures see Supplemental
Information.
Mice
Gene targeted mice were bred in an SPF facility at NIMR. For induction of Cre
expression, mice were treated with tamoxifen (2 mg/day) for 5 days. Radiation
chimeras were generated using standard protocols. For retrovirus-mediated
gene transfer, bone-marrow cells were infected in vitro with retroviruses prior
to reconstitution of irradiated recipients. If required, chimeric mice were
treated with tamoxifen 6–8 weeks after reconstitution.
Immunoblotting
Splenic B cells were purified by depletion with antibodies to CD43 and CD1d,
and lysates were prepared using RIPA buffer. Immunoblotting was performed
using standard procedures.
B Cell Survival Assay
Purified splenic B cells were cultured for 4 days with or without BAFF. Absolute
numbers of live B cells were assessed using ToPro3 exclusion.
RNA Analysis
Follicular B cells (B220+CD93CD23+IgM+) were sorted from spleens 10 days
after start of tamoxifen treatment. RNA was isolated using RNEasy mini kit
(QIAGEN) and used for microarray or RNASeq analysis.
Statistical Analysis
All statistical comparisonswere carried out using the nonparametric two-tailed
Mann-Whitney test. Statistically significant differences are indicated on the
figures: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2012.11.015.ACKNOWLEDGMENTS
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